Literature DB >> 26378152

LKB1 deletion causes early changes in atrial channel expression and electrophysiology prior to atrial fibrillation.

Grace E Kim1, Jenna L Ross2, Chaoqin Xie3, Kevin N Su1, Vlad G Zaha2, Xiaohong Wu2, Monica Palmeri2, Mohammed Ashraf2, Joseph G Akar2, Kerry S Russell2, Fadi G Akar3, Lawrence H Young4.   

Abstract

AIMS: Liver kinase B1 (LKB1) is a protein kinase that activates the metabolic regulator AMP-activated protein kinase (AMPK) and other related kinases. Deletion of LKB1 in mice leads to cardiomyopathy and atrial fibrillation (AF). However, the specific role of the LKB1 pathway in early atrial biology remains unknown. Thus, we investigated whether LKB1 deletion altered atrial channel expression and electrophysiological function in a cardiomyocyte-specific knockout mouse model. METHODS AND
RESULTS: We performed a systematic comparison of αMHC-Cre LKB1(fl/fl) and littermate LKB1(fl/fl) male mice. This included analysis of gene expression, histology, and echocardiography, as well as cellular and tissue-level electrophysiology using patch-clamp recordings in vitro, optical mapping ex vivo, and ECG recordings in vivo. At postnatal day 1, atrial depolarization was prolonged, and Nav1.5 and Cx40 expression were markedly down-regulated in MHC-Cre LKB1(fl/fl) mice. Inward sodium current density was significantly decreased in MHC-Cre LKB1(fl/fl) neonatal atrial myocytes. Subsequently, additional alterations in atrial channel expression, atrial fibrosis, and spontaneous onset of AF developed by 2 weeks of age. In adult mice, abnormalities of interatrial conduction and bi-atrial electrical coupling were observed, likely promoting the perpetuation of AF. Mice with AMPK-inactivated hearts demonstrated modest overlap in channel expression with MHC-Cre LKB1(fl/fl) hearts, but retained normal structure, electrophysiological function and contractility.
CONCLUSIONS: Deletion of LKB1 causes early defects in atrial channel expression, action potential generation and conduction, which precede widespread atrial remodelling, fibrosis and AF. LKB1 is critical for normal atrial growth and electrophysiological function. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Cellular signalling pathways; LKB1

Mesh:

Substances:

Year:  2015        PMID: 26378152      PMCID: PMC4571838          DOI: 10.1093/cvr/cvv212

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  54 in total

1.  Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.

Authors:  M H Gollob; M S Green; A S Tang; T Gollob; A Karibe; A S Ali Hassan ; F Ahmad; R Lozado; G Shah; L Fananapazir; L L Bachinski; R Roberts; A S Hassan
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

2.  Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart.

Authors:  H Nakajima; H O Nakajima; O Salcher; A S Dittiè; K Dembowsky; S Jing; L J Field
Journal:  Circ Res       Date:  2000-03-17       Impact factor: 17.367

3.  Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a.

Authors:  G Alex Papadatos; Polly M R Wallerstein; Catherine E G Head; Rosemary Ratcliff; Peter A Brady; Klaus Benndorf; Richard C Saumarez; Ann E O Trezise; Christopher L-H Huang; Jamie I Vandenberg; William H Colledge; Andrew A Grace
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

4.  MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm.

Authors:  Jérôme Boudeau; Annette F Baas; Maria Deak; Nick A Morrice; Agnieszka Kieloch; Mike Schutkowski; Alan R Prescott; Hans C Clevers; Dario R Alessi
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

5.  Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.

Authors:  Nabeel Bardeesy; Manisha Sinha; Aram F Hezel; Sabina Signoretti; Nathaniel A Hathaway; Norman E Sharpless; Massimo Loda; Daniel R Carrasco; Ronald A DePinho
Journal:  Nature       Date:  2002-09-12       Impact factor: 49.962

6.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.

Authors:  Jose M Lizcano; Olga Göransson; Rachel Toth; Maria Deak; Nick A Morrice; Jérôme Boudeau; Simon A Hawley; Lina Udd; Tomi P Mäkelä; D Grahame Hardie; Dario R Alessi
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

7.  AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury.

Authors:  Raymond R Russell; Ji Li; David L Coven; Marc Pypaert; Christoph Zechner; Monica Palmeri; Frank J Giordano; James Mu; Morris J Birnbaum; Lawrence H Young
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

8.  Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.

Authors:  Michael Arad; Ivan P Moskowitz; Vickas V Patel; Ferhaan Ahmad; Antonio R Perez-Atayde; Douglas B Sawyer; Mark Walter; Guo H Li; Patrick G Burgon; Colin T Maguire; David Stapleton; Joachim P Schmitt; X X Guo; Anne Pizard; Sabina Kupershmidt; Dan M Roden; Charles I Berul; Christine E Seidman; J G Seidman
Journal:  Circulation       Date:  2003-06-02       Impact factor: 29.690

9.  Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD.

Authors:  A F Baas; J Boudeau; G P Sapkota; L Smit; R Medema; N A Morrice; D R Alessi; H C Clevers
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

10.  LKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process.

Authors:  Cevher Ozcan; Emily Battaglia; Rebeccah Young; Gen Suzuki
Journal:  J Am Heart Assoc       Date:  2015-03-15       Impact factor: 5.501

View more
  13 in total

1.  Cardiomyocyte d-dopachrome tautomerase protects against heart failure.

Authors:  Yina Ma; Kevin N Su; Daniel Pfau; Veena S Rao; Xiaohong Wu; Xiaoyue Hu; Lin Leng; Xin Du; Marta Piecychna; Kenneth Bedi; Stuart G Campbell; Anne Eichmann; Jeffrey M Testani; Kenneth B Margulies; Richard Bucala; Lawrence H Young
Journal:  JCI Insight       Date:  2019-09-05

2.  Molecular Mechanism of the Association Between Atrial Fibrillation and Heart Failure Includes Energy Metabolic Dysregulation Due to Mitochondrial Dysfunction.

Authors:  Cevher Ozcan; Zhenping Li; Gene Kim; Valluvan Jeevanandam; Nir Uriel
Journal:  J Card Fail       Date:  2019-08-12       Impact factor: 5.712

Review 3.  Mouse models of spontaneous atrial fibrillation.

Authors:  Joshua A Keefe; Mohit M Hulsurkar; Svetlana Reilly; Xander H T Wehrens
Journal:  Mamm Genome       Date:  2022-09-29       Impact factor: 3.224

Review 4.  The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis.

Authors:  Jordi Heijman; Vincent Algalarrondo; Niels Voigt; Jonathan Melka; Xander H T Wehrens; Dobromir Dobrev; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2015-12-23       Impact factor: 10.787

Review 5.  Transcriptional factors in calcium mishandling and atrial fibrillation development.

Authors:  Wenli Dai; Sneha Kesaraju; Christopher R Weber
Journal:  Pflugers Arch       Date:  2021-05-18       Impact factor: 4.458

Review 6.  Electrophysiological Mechanisms of Bayés Syndrome: Insights from Clinical and Mouse Studies.

Authors:  Gary Tse; Eric Tsz Him Lai; Jie Ming Yeo; Bryan P Yan
Journal:  Front Physiol       Date:  2016-05-31       Impact factor: 4.566

7.  Deletion of Lkb1 in adult mice results in body weight reduction and lethality.

Authors:  Tizhong Shan; Yan Xiong; Shihuan Kuang
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

8.  Angiotensin II affects inflammation mechanisms via AMPK-related signalling pathways in HL-1 atrial myocytes.

Authors:  Nami Kim; Youngae Jung; Miso Nam; Mi Sun Kang; Min Kyung Lee; Youngjin Cho; Eue-Keun Choi; Geum-Sook Hwang; Hyeon Soo Kim
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

Review 9.  Arrhythmogenic Substrates for Atrial Fibrillation in Obesity.

Authors:  Ellen R Lubbers; Morgan V Price; Peter J Mohler
Journal:  Front Physiol       Date:  2018-10-22       Impact factor: 4.566

Review 10.  Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes.

Authors:  Basil S Karam; Alejandro Chavez-Moreno; Wonjoon Koh; Joseph G Akar; Fadi G Akar
Journal:  Cardiovasc Diabetol       Date:  2017-09-29       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.